RecruitingNCT06781437

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Studying OBSOLETE: Lymphoproliferative syndrome

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Principal Investigator: Pier Luigi Zinzani, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment: 5500 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2027

Study locations (1)

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Bologna, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06781437 on ClinicalTrials.gov

Other trials for OBSOLETE: Lymphoproliferative syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06730126
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for OBSOLETE: Lymphoproliferative syndrome →

← Back to all trials